Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Coffee silverskin may be a beneficial and safe ingredient for cosmetics, offering hydration, firmness, and potential hair growth benefits.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

Fructus Psoraleae may help treat hair loss by inhibiting 5-α reductase and affecting the Nrf2-Keap1 pathway.

Nepenthes kampotiana extract can potentially prevent hair loss and could be an effective treatment for common baldness.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Dutasteride is effective for treating hair loss.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Green tea extract may help reduce excessive hair growth.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

The document discusses new insights into how hormones affect male sexual health and related conditions.

β-sitosterol and brassicasterol may help treat hair loss.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Amarantha hair oil contains β-sitosterol, which helps promote hair growth.